admin

admin

Retatrutide Research: Triple GIP/GLP-1/Glucagon Mechanisms, Phase 3 Evidence, and Laboratory Applications

RT20mg

Retatrutide, also known as LY3437943, is a synthetic peptide engineered to activate three metabolically important receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR). This triple-receptor profile distinguishes retatrutide from single GLP-1 agonists and…